The Mesoblast Ltd (ASX: MSB) share price is in focus after the company reported a sharp increase in revenue to US$120.3 million for the 2026 financial year and a 44% reduction in net loss.

What did Mesoblast report?

• Total revenue climbed to US$120.3 million, up from US$17.2 million in FY2025
• Gross profit reached US$103.6 million, with gross profit excluding amortisation at US$109.7 million
• Net loss reduced by 44% to US$57.5 million, down from US$102.1 million last year
• Net operating cash spend was US$43.8 million, improved from US$50.0 million in FY2025
• Period-end cash balance stood at US$103 million with a new US$125 million five-year credit facility
• US commercial launch of RYONCIL generated US$115.2 million in net revenue

What else do investors need to know?

Mesoblast successfully launched RYONCIL in the US for children with steroid-refractory acute graft versus host disease, securing broad adoption at major paediatric transplant centres and major payer coverage. The median time from patient identification to treatment dropped from 29 days at launch to 8 days.

The company is expanding RYONCIL’s use to adults with severe SR-aGvHD, a market potentially three times larger than the paediatric segment, and progressing a registration trial as part of a second-line regimen with ruxolitinib. Mesoblast also obtained FDA clearance for a trial in children with Duchenne muscular dystrophy.

For its rexlemestrocel-L platform, Mesoblast completed treatment of 350 patients in a Phase 3 clinical trial for chronic low back pain, positioning the company to address a market worth over US$10 billion. Top-line results are expected in mid-2027.

What did Mesoblast management say?

Mesoblast’s CEO, Dr. Silviu Itescu, commented:

We are very pleased to report a strong full year gross profit of US$104M for the fiscal year 2026. The financial result is a product of continued growth in RYONCIL market adoption and focus on disciplined capital allocation while investing in our high-value opportunities.

What’s next for Mesoblast?

Looking ahead, Mesoblast plans to expand RYONCIL’s label to adults with severe SR-aGvHD and further advance development for chronic low back pain using rexlemestrocel-L, with a pivotal data readout due next year. The company also aims to develop next-generation cell therapies through new CAR-MSC and oncolytic virus technologies, broadening its pipeline for inflammatory and immunological diseases.

With a solid cash balance and new funding in place, Mesoblast intends to continue investing in high-value clinical programs and commercial execution, maintaining its position as a sector innovator.

Mesoblast share price snapshot

The Mesoblast share price has underperformed the S&P/ASX 200 index (ASX: XJO) with a decline of around 5% over the past 12 months.

View Original Announcement

The post Mesoblast earnings: Strong revenue growth and operational milestones in FY26 appeared first on The Motley Fool Australia.

More reading

• ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus
• Mesoblast shares are up sharply. Is this biotech still undervalued?
• Here are the top 10 ASX 200 shares today
• Mesoblast share price jumps on blockbuster news
• 3 ASX 200 shares tipped to grow 45% to 75% over the next 12 months

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Eagers Automotive Ltd (ASX: APE) share price could be in focus after the company delivered a record half-year result, with revenue rising 24% to $8.05 billion and net profit after tax up 23% to $165.2 million.

What did Eagers Automotive report?

• Revenue rose 24% to $8,053.5 million compared to 1H25
• Statutory net profit after tax increased 23% to $165.2 million
• Underlying EBITDA up 23% to $364.6 million
• Ordinary interim dividend up 4% to 25 cents per share, fully franked
• Liquidity at $2.61 billion and net debt at $674.9 million as at 30 June 2026
• Acquisition of CanadaOne Auto Group contributed $40.5 million in profit before tax across two months

What else do investors need to know?

Eagers Automotive entered the Canadian market by acquiring a 65% stake in CanadaOne Auto Group, which made an immediate positive impact on group results and expanded the company’s international footprint. The strategic investment saw the company issue exchangeable shares as partial consideration, strengthening the balance sheet and broadening shareholder alignment.

In Australia, Eagers increased its market share in new vehicles, reaching 15.9%, up from 13.8% a year ago. The group also signed a non-binding agreement to divest its franchised automotive business in New Zealand—retaining the easyauto123 operations—to redeploy capital into other growth initiatives.

What’s next for Eagers Automotive?

Eagers Automotive expects a full second-half contribution from CanadaOne Auto Group, with further opportunities for organic and acquisitive growth in North America. The company remains focused on optimising its partner portfolio, expanding its independent pre-owned vehicle business, and leveraging its unique scale and brand partnerships to outperform industry benchmarks.

Management cited a disciplined approach to capital allocation and cost management, aiming for sustainable, industry-leading returns. While mindful of current economic conditions and higher interest rates, the board remains optimistic about growth prospects in both the Australian and Canadian markets.

Eagers Automotive share price snapshot

The Eagers Automotive share price has modestly outperformed the S&P/ASX 200 index (ASX: XJO) on a 12-month basis with a gain of over 6%.

View Original Announcement

The post Eagers Automotive posts record 1H26 earnings on strong Canadian expansion appeared first on The Motley Fool Australia.

More reading

• How much superannuation is needed to target a $50,000 annual passive income?
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The Brightstar Resources Ltd (ASX: BTR) share price is in focus after the company announced exceptionally wide, high-grade gold intercepts from infill drilling at its Two Mile Hill-Shillington deposit, part of the Sandstone Gold Project. Standout results include a 225.7 metre interval at 3.11 grams per tonne gold, with individual assays up to 449 grams per tonne.

What did Brightstar Resources report?

• Received further assay results from reverse circulation and diamond core drilling at Two Mile Hill-Shillington.
• Key intercepts include 225.7m @ 3.11g/t Au (including 19m @ 24.3g/t Au) and 194m @ 2.10g/t Au (including 13m @ 4.35g/t Au).
• Current Mineral Resource Estimate: 14.6 million tonnes at 1.6g/t Au for 731,000 ounces gold at Two Mile Hill-Shillington.
• Infill drilling targets areas for potential underground mining and aims to upgrade resources to Indicated classification.
• Visible gold was observed throughout significant intersections, typically associated with galena and pyrite.

What else do investors need to know?

Drilling at Sandstone is ongoing, with both RC and diamond rigs active across multiple deposits as part of workstreams for the pre-feasibility study. These latest results support Brightstar’s plans to potentially include underground mining in its upcoming study.

The infill drilling builds on recent success, following earlier results such as 305m at 1.8g/t Au from extension drilling. Initial work has also identified a newly discovered “Shirvington Zone” at Two Mile Hill, revealing even broader mineralisation than previously modelled.

What did Brightstar Resources management say?

Managing Director Alex Rovira said:

The latest results continue to demonstrate the broad widths of the Two Mile Hill deposit and high-grade nature of the quartz veining within the host tonalite, with individual grades reaching 449g/t Au. These infill results are hugely encouraging for a potential future underground mining operation at Two Mile Hill, which is currently being assessed by Brightstar and Entech for inclusion in the upcoming pre-feasibility study.

What’s next for Brightstar Resources?

Brightstar plans to incorporate the new infill drill results into its next Mineral Resource Estimate and pre-feasibility study, both set for release in November 2026. The ongoing drilling programs seek to further enhance geological confidence and explore extensions at depth.

Construction of the 1.5Mtpa processing plant is already underway as part of the broader Goldfields Hub development, with initial gold production targeted for June 2027. The company aims to progress towards large-scale underground and open pit mining across its Western Australian gold assets.

Brightstar Resources share price snapshot

Over the past 12 months, Brightstar Resources shares have risen 32%, outperforming the All Ordinaries Index (ASX: XAO), which has risen 1% over the same period.

View Original Announcement

The post Brightstar Resources posts record gold drilling intercepts at Sandstone appeared first on The Motley Fool Australia.

More reading

• Brightstar Resources results: 4.5Moz gold resource and production plans advance
• Brightstar Resources provides Goldfields Project update as construction forges ahead
• Brightstar Resources drills thick gold intercepts to expand Sandstone scale

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.